MedTrace Logo

Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease

NCT05267028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2023-03-31

No results posted yet for this study

Summary

EYE-TAR(AD+) is an observational study based on the same design as the princeps EYE-TAR(MA) study, but with a larger number of patients and including an additional evaluation of Facial emotion recognition (based on a more ecological material), in order to reinforce conclusions of the study EYE-TAR(MA) https://doi.org/10.1016/j.npg.2020.08.003.

The main objective is to confirm that facial emotion recognition can be improved in AD using the "Training of Affect Recognition program" (TAR).

The Secondary Objectives are to:

Evaluate the impact of the "Training of Affect Recognition program" (TAR) on oculomotor behavior in a situation of social cognition, on behavioral disorders and on caregiver burden.

Confirm that improvement in facial emotion recognition is related to modification of observation strategies.

Confirm the link between improved recognition of facial emotions, reduced behavioral disorders and caregiver burden.

Conditions

  • Alzheimer's Dementia (AD)
  • Family Caregivers

Interventions

OTHER

AD-TAR

12 sessions in groups of 4 subject, over 6 weeks (2 sessions per week), using a rehabilitation program named Training of Affect Recognition (TAR).

OTHER

AD-Cognitive Stimulation

12 sessions in groups of 4 subject, over 6 weeks (2 sessions per week), using classic cognitive stimulation workshops.

Sponsors & Collaborators

  • Centre Hospitalier Princesse Grace

    collaborator OTHER

  • Universite Cote d'Azur

    collaborator OTHER

  • Association de Recherche Bibliographique pour les Neurosciences

    lead OTHER

Principal Investigators

  • Sandrine LOUCHART DE LA CHAPELLE, MD PhD · Centre Mémoire, Centre de Gérontologie Clinique RAINIER III, Princess Grace Hospital, Monaco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-10
Primary Completion
2023-03-22
Completion
2023-03-22

Countries

  • Monaco

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05267028 on ClinicalTrials.gov